May 30, 2025

SIBIONICS CGM Device – GS3 Debuts at ATTD 2025

SIBIONICS sales manager introduces the new product GS3 to the visitor. Image courtesy: PRNewswire
SIBIONICS sales manager introduces the new product GS3 to the visitor. Image courtesy: PRNewswire

The 2025 Advanced Technologies & Treatments for Diabetes (ATTD) conference took place in Amsterdam, Netherlands, bringing together top experts and the latest innovations in diabetes care. SIBIONICS participated in this prestigious event, unveiling one of the world’s thinnest CGM device—GS3, showcasing its latest breakthrough in glucose monitoring technology.

.

Image courtesy: LinkedIn

.

SIBIONICS GS3 Achieves CE Certification

With its ultra-compact design and 3-second activation, GS3 quickly became a highlight at ATTD 2025 with its revolutionary thinness of just 2.9mm, comparable to a small coin.

.

It offers:

  • Feather-light weight of only 1.5g, making it almost unnoticeable when worn
  • 3 connection methods, ensuring compatibility with a variety of smartphones
  • NFC-enabled 3-second connection, allowing instant pairing with a simple tap
  • By integrating multiple AI capabilities, GS3 helps users better understand their glucose data and enables more effective self-management of their glucose levels. In addition, GS3 can connect directly with Smartwatch and Receiver, meeting the personalized needs of a wider range of users, especially children and the elderly.
  • Continuous algorithm enhancements further improve monitoring stability and accuracy, providing a more reliable glucose management solution for users.

.

Logo courtesy: SIBIONICS LinkedIn

.

In-Depth Exploration of CGM & CKM in Clinical Applications

At ATTD 2025, SIBIONICS hosted the SIBIONICS Symposium, where experts shared research findings on the clinical applications of CGM and the differentiation of AGP (Ambulatory Glucose Profile) patterns among various patient groups. These insights contribute to the advancement of precision diabetes treatment and offer stronger scientific and clinical support.

CKM made its debut at the symposium, where clinical experts conducted an in-depth study on its potential for Type 1 diabetes management and, for the first time, shared preliminary findings at the conference.

With the launch of GS3, SIBIONICS continues to lead CGM innovation, aiming to provide a lighter, more precise, and smarter glucose monitoring experience for people with diabetes worldwide.

Source

For more news:

Smart Gadgets that Help to Keep You in Good Health

(Visited 77 times, 1 visits today)

Share:

Facebook
Twitter
WhatsApp
LinkedIn

 

Comments are closed.

Social Media

Most Popular

YASH Technologies Achieves the AWS Generative AI Competency
YASH Technologies Achieves the AWS Generative AI Competency
Books-A-Million's 24th Coffee for the Troops Campaign Surpasses 80,000 Bags Donated 22
Books-A-Million's 24th Coffee for the Troops Campaign Surpasses 80,000 Bags Donated
UNice Partners with Student Beans and Beans iD to Offer Exclusive Discounts
UNice Partners with Student Beans and Beans iD to Offer Exclusive Discounts for Students, Graduates, and Key Workers
SignaPay Opens New 15,000-Square-Foot Headquarters in Irving, Texas
SignaPay Opens New 15,000-Square-Foot Headquarters in Irving, Texas

Related Posts